Corona Remedies IPO: 137x subscribed, lists at 38% premium on NSE-BSE

• Corona Remedies IPO listed on December 15, 2025, making a strong market entry.
• The IPO listed at a 38% premium, opening at ₹1,470 on NSE and ₹1,452 on BSE.
• The IPO was oversubscribed 137.04 times overall, with Qualified Institutional Buyers (QIBs) subscribing 278.52 times.
• The ₹655.37 crore IPO was entirely an Offer For Sale (OFS).
• The IPO's price band was set between ₹1,008 and ₹1,062 per share.

Why It Matters: Corona Remedies IPO's strong listing shows high investor demand and market confidence.